We have established a policy for reducing GHG emissions based on rece...
It is estimated that there are approximately 250,000 children ...
Targets Progress Initiatives Initiatives for Pharmaceuticals Ext...
Contributing to sustainable social development through business activit...
We have established a Sales Information Activities Supervisory Division w...
ONO PHARMA KOREA has been supporting the childhood cancer NGO "Hanbi...
Growth Strategy and Talent Strategy Towards Achievement of Corporate Phi...
Reporting System We have established internal and external points o...
Our Stance on Sustainable Procurement Joining the PSCI (Pharmaceutica...
Risk Management Business Continuity Plan (BCP) Major Risks Infor...
We actively support the blood donation activities of the Japanese Red C...
Support for Disease Prevention, Early Detection and Early Treatment ...
Our efforts to promote diversity focus on three main areas: management*, ...
Sustainability information We have received independent assurance so a...
Basic policy The ONO Group will strive to maintain and ...
As social structures evolve due to factors such as technological innovati...
Action Policies for Improving Access to Healthcare Research and Devel...
In October 2023, we rolled out the Global HR System with the aim of enabl...
ONO Pharmaceutical’s Compliance System Initiatives to Strengthen Comp...
Employees at each worksite actively participate in cleaning activities arou...